JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JCM.01351-07v1
46/1/214    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Top, J.
Right arrow Articles by Bonten, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Top, J.
Right arrow Articles by Bonten, M.
Journal of Clinical Microbiology, January 2008, p. 214-219, Vol. 46, No. 1
0095-1137/08/$08.00+0     doi:10.1128/JCM.01351-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Emergence of Clonal Complex 17 Enterococcus faecium in The Netherlands{triangledown}

Janetta Top,1* Rob Willems,1 Saskia van der Velden,1 Miranda Asbroek,1 and Marc Bonten1,2

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands,1 Julius Center for Health Studies and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands2

Received 6 July 2007/ Returned for modification 11 September 2007/ Accepted 22 October 2007

The global emergence of vancomycin-resistant Enterococcus faecium has been characterized as the clonal spread of clonal complex 17 (CC17) E. faecium. CC17 was defined upon multilocus sequence typing and is characterized by resistance to quinolones and ampicillin and the presence of the enterococcal surface protein (Esp) in the majority of isolates. The recently noticed increased incidence of vancomycin-susceptible CC17 E. faecium infections in our hospital initiated a nationwide study to determine ecological changes among enterococcal infections. The data and strain collections were obtained from 26 (38%) and 9 (14%) of 66 microbiology laboratories in The Netherlands. E. faecium and E. faecalis were distinguished by multiplex PCR; all E. faecium isolates were genotyped by multiple-locus variable-number tandem-repeat analysis (MLVA), and the presence of esp was identified by PCR. Average numbers of ampicillin-resistant enterococcal isolates from normally sterile body sites per hospital increased from 5 ± 1 in 1994 to 25 ± 21 in 2005. Among all enterococcal bloodstream infections, the proportions of ampicillin-resistant E. faecium (AREF) increased from 4% in 1994 to 20% in 2005 (P < 0.001). All E. faecalis isolates were susceptible to ampicillin, whereas 78% of the E. faecium isolates were resistant (49% of these contained esp). Genotyping revealed that 86% of AREF isolates belonged to CC17, including four dominant MLVA types found in ≥3 hospitals, accounting for 64% of the AREF isolates. Infections caused by CC17 E. faecium has increased nationwide, especially in university hospitals due to the clonal spread of four MLVA types, and seems associated with acquisition of the esp gene.


* Corresponding author. Mailing address: Department of Medical Microbiology, University Medical Center Utrecht, G04.614, P.O. Box 85500, 3508 GA Utrecht, The Netherlands. Phone: 31-88-7557627. Fax: 31-30-2541770. E-mail: j.top{at}umcutrecht.nl

{triangledown} Published ahead of print on 31 October 2007.


Journal of Clinical Microbiology, January 2008, p. 214-219, Vol. 46, No. 1
0095-1137/08/$08.00+0     doi:10.1128/JCM.01351-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.